相关实验视频
Updated: Sep 13, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
对甲状腺癌中APOBEC突变的全面洞察:预后和治疗发现
Wei Luo1, Feng Liu2, Mengyu Li3
1Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Biological procedures online
|July 27, 2025
概括
APOBEC突变是甲状腺癌的关键,与预后不佳和免疫逃避有关. 抑制APOBEC2对抑制瘤生长和提高免疫疗法的有效性显示出希望.
科学领域:
- 遗传学和基因组学 在
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- APOBEC (阿波蛋白B mRNA编辑酶,催化多类) 家族与各种人类癌症有关.
- APOBEC家族成员的临床意义和生物学作用仍未得到充分研究.
- 这项研究重点关注APOBEC家族成员及其在甲状腺癌 (THCA) 中的突变.
研究的目的:
- 描述APOBEC家族成员和癌症突变的分布和临床相关性.
- 调查APOBEC突变在THCA进展和预后中的作用.
- 探索APOBEC2作为THCA的治疗点.
主要方法:
- 综合生物信息学和统计分析.
- 使用全外体序列 (WES),RNA序列 (RNA-seq) 和单细胞RNA序列 (scRNA-seq).
- 采用了体外和体内模型,包括药物敏感性测定和动物研究.
主要成果:
- 在THCA中,APOBEC突变是显著的,与预后不佳,免疫逃避和恶性进展相关.
- 开发并验证了一种基于机器学习的APOBEC突变发生的预后模型.
- 抑制APOBEC2抑制了瘤生长,转移和糖解,同时增强了抗瘤免疫力和免疫疗法的有效性.
结论:
- APOBEC突变作为攻击性THCA表型,预后和免疫治疗反应的潜在生物标志物.
- 多omics测序和实验验证为APOBEC的作用提供了全面的理解.
- 针对APOBEC2为THCA提供了一个有前途的治疗策略.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

